Microglial activation augments AD pathogenesis, and thus, an altered expression of triggering receptor expressed on myeloid cells 2 (Trem2), that acts as a risk factor for AD, may reduce the compaction of Aβ and attenuate the cognitive decline (Rai et al., 2020a). Here, TREM2 is linked to Alzheimer disease.